Volunteer Yoga Instructor Helps Multiple Sclerosis Patients
Gail Pickens-Barger is a doTERRA Elite Wellness Advocate who has been helping students to improve their fitness for 15 years. The yoga instructor…
Articles by Patricia Silva, PhD
Review Highlights Long List of Unmet Needs For MS Patients
In a special feature published in the journal American Health & Drug Benefits, authors Stanton R. Mehr, President of…
New Study Focuses on Sleep Troubles and Quality of Life in MS Patients
A new study investigated the influence of sleep disturbance, fatigue and disability on the quality of life (QOL) in multiple sclerosis…
NIH Grant to Advance Multiple Sclerosis Therapy Targeting Remyelination
Novoron Bioscience, Inc., a biotech company focused on developing therapies for disorders of the central nervous system, recently announced…
MS Patients Are Adequately, But Not Optimally, Treated for Depression
A new Canadian study, published in the International Journal of MS Care, has concluded that the majority…
MS Fatigue, Cognitive Impairments Are Main Reasons Patients Lose Their Jobs
Difficulties with cognitive function and fatigue are the main reasons patients with multiple sclerosis (MS) struggle to stay gainfully employed, a new…
Multiple Sclerosis Takes a Physical and Psychological Toll on Caregivers, Too
People caring for multiple sclerosis (MS) patients can have substantial physical and psychological health concerns, and their care can adversely…
Top 10 Multiple Sclerosis Articles of 2015
Multiple Sclerosis News Today has reported the latest therapies, clinical trial developments, and events in multiple sclerosis (MS) on a…
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
GeNeuro, a company developing therapies for neurological and autoimmune disorders, recently announced the initiation of a Phase 2b clinical…
MS Patients Using New Web-based Program to Manage and Integrate Care
A team of researchers from the Netherlands have developed an interactive web-based program called MSmonitor that offers multiple sclerosis patients a…
New MS Drug Therapy Based on Monomethyl Fumarate Moving Along in Testing
Alkermes plc, a biopharmaceutical company focused on therapies for the treatment of central nervous system (CNS) disorders, announced that…
New MS Drug Shows ‘Excellent Profile’ in Preclinical Tests Against Approved Therapy
Akaal Pharma, a developer of small molecule drugs for the treatment of inflammation and autoimmune diseases including multiple sclerosis…
MS Physical Therapy in Need of Proper Study, Experts Say
The National Multiple Sclerosis Society announced that a panel of experts led a comprehensive review of 142 published studies addressing…
MS Nerve Degeneration Triggered by Chain Reaction in Cells
Researchers in the United Kingdom recently discovered that a small molecule triggers the destruction of axons, a phenomenon observed in neurodegenerative diseases…
2 New Treatments for Relapsing-Remitting MS Now Available in New Zealand
The Multiple Sclerosis Society of New Zealand (MSNZ) announced that PHARMAC has agreed with its request to finance two novel first-in-line therapies for…
2016 Multiple Sclerosis Forum to Focus on Distinctions in Disease Forms
Dr. Jerry S. Wolinsky of the University of Texas in Houston, will give the first Kenneth P. Johnson Memorial Lecture at the opening…
Study Recruiting MS Patients to Assess Exercise and Behavioral Therapy
Dr. Bradley Bowser, a South Dakota State University (SDSU) researcher and assistant professor, is investigating whether the practice of exercise,…
In Multiple Sclerosis Study, Vitamin D Shown to Aid Myelin Repair
A new study in the Journal of Cell Biology suggests that vitamin D activates a receptor involved in myelin…
MS Therapy Aims to Slow Brain Inflammation with Fewer Side Effects
A research team from the University of Alberta, Canada, is exploring a new therapeutic way of reducing brain inflammation in multiple sclerosis…
MS Researchers at Japanese Hospital to Use Novel MRI Technology
Juntendo University Hospital, the first medical school in Japan to adopt Western medicine, recently signed a research agreement with …
Tips for Managing Multiple Sclerosis During the Holidays
The holidays can be stressful on everyone, and especially on those with multiple sclerosis (MS). A health specialist is offering these eight suggestions to MS patients…
Relapsing Multiple Sclerosis Treatment Now Available in Japan
Takeda Pharmaceutical, a pharmaceutical company based in Osaka, Japan, recently announced that a widely approved drug treatment for the prevention of…
Brickell Biotech Targeting MS and Other Autoimmune Diseases
Brickell Biotech, Inc., a pharmaceutical company developing novel therapies in the field of dermatology, recently announced it has exclusive worldwide…
RRMS Clinical Study of New Antibiotic Therapy Nearing End
RedHill Biopharma, Ltd., recently announced the conclusion of the last dosing and patient follow-up visit for its Phase 2a…
MS Society of Canada Helps Fund Pediatric Study of Gut Bacteria
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation recently announced the funding of…
Experimental Relapsing-Remitting MS Drug Treatment Advancing
Synthetic Biologics, which specializes in the development of therapies for pathogen-specific diseases, recently announced the publication of new and positive data on…
National Multiple Sclerosis Society Awards Wisconsin Researcher With Grant To Fuel Promising Study
The National Multiple Sclerosis Society awarded a $700,000 research grant to Dr. Bonnie Dittel, a senior investigator at the BloodCenter…
People with Relapsing NMOD Invited to Enter Phase 3 Study
The National Multiple Sclerosis Society recently announced that a research team is recruiting 132 patients with a diagnosis of…
APF Scholarship Goes to Study of Stigma and Depression in MS
Ms. Margaret Cadden, a Pennsylvania State University doctoral student in Clinical Psychology, has been selected by the American Psychological Foundation…
Opexa Therapeutics’ MS Therapy Selected as ‘Top Project to Watch’
Opexa Therapeutics announced that it has been named one of the “Top Projects to Watch” for the third consecutive year. A panel…